Arnold C. Hanish's most recent trade in Omeros Corporation was a trade of 15,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Omeros Corporation | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
Omeros Corporation | Arnold C. Hanish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
Omeros Corporation | Arnold C. Hanish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.30 per share. | 22 May 2023 | 5,000 | 5,000 (0%) | 0% | 5.3 | 26,500 | Common Stock |
Omeros Corporation | Arnold C. Hanish | Director | Sale of securities on an exchange or to another person at price $ 6.46 per share. | 22 May 2023 | 5,000 | 0 (0%) | 0% | 6.5 | 32,300 | Common Stock |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,440 | 1,440 (0%) | 0% | 0 | Common Stock | |
Omeros Corporation | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Purchase of securities on an exchange or from another person at price $ 0.18 per share. | 03 Jun 2022 | 28,000 | 46,350 (0%) | 0% | 0.2 | 5,152 | Common Stock |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Omeros Corporation | Arnold C. Hanish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 10,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
Omeros Corporation | Arnold C. Hanish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.44 per share. | 08 Sep 2021 | 10,000 | 10,000 (0%) | 0% | 9.4 | 94,400 | Common Stock |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 10 Aug 2021 | 7,000 | 18,350 (0%) | 0% | 0.9 | 6,167 | Common Stock |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Salarius Pharmaceuticals Inc | Arnold C. Hanish | Director | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 21 Aug 2020 | 4,000 | 11,350 (0%) | 0% | 1.0 | 3,920 | Common Stock |
Omeros Corporation | Arnold C. Hanish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) |